DBV Technologies will participate in investor conferences in March

DBV Technologies, a late-stage biopharmaceutical company, announced its participation in several investor conferences in March 2026. The company plans to speak at the Citizens Life Sciences Conference on March 10, where it will hold a Fireside Chat at 1:40 p.m. Eastern Time. It will also participate in one-on-one meetings at the Leerink Partners Global Healthcare Conference on March 11.

Investors and interested parties can register to watch the Citizens JMP Conference presentation live. A recording will be available in the Events section of the DBV Technologies website for 90 days following the event.